BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33964415)

  • 1. Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting.
    Kim E; Williams RM; Eyestone E; Cordon M; Smith L; Davis K; Luta G; Anderson ED; McKee B; Batlle J; Ramsaier M; Howell J; Parikh V; Geronimo M; Stanton C; Niaura R; Abrams D; Taylor KL;
    Contemp Clin Trials; 2021 Jul; 106():106429. PubMed ID: 33964415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.
    Taylor KL; Hagerman CJ; Luta G; Bellini PG; Stanton C; Abrams DB; Kramer JA; Anderson E; Regis S; McKee A; McKee B; Niaura R; Harper H; Ramsaier M
    Lung Cancer; 2017 Jun; 108():242-246. PubMed ID: 28216065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program.
    Raz DJ; Wu G; Nelson RA; Sun V; Wu S; Alem A; Haupt EC; Ismail MH; Gould MK
    Clin Lung Cancer; 2019 Jan; 20(1):e115-e122. PubMed ID: 30585165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
    Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
    Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved motivation and readiness to quit shortly after lung cancer screening: Evidence for a teachable moment.
    Williams RM; Cordon M; Eyestone E; Smith L; Luta G; McKee BJ; Regis SM; Abrams DB; Niaura RS; Stanton CA; Parikh V; Taylor KL;
    Cancer; 2022 May; 128(10):1976-1986. PubMed ID: 35143041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Enrollment of Older Smokers in Six Smoking Cessation Trials in the Lung Cancer Screening Setting: The Smoking Cessation at Lung Examination (SCALE) Collaboration.
    Eyestone E; Williams RM; Luta G; Kim E; Toll BA; Rojewski A; Neil J; Cinciripini PM; Cordon M; Foley K; Haas JS; Joseph AM; Minnix JA; Ostroff JS; Park E; Rigotti N; Sorgen L; Taylor KL
    Nicotine Tob Res; 2021 Nov; 23(12):2037-2046. PubMed ID: 34077535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.
    Taylor KL; Deros DE; Fallon S; Stephens J; Kim E; Lobo T; Davis KM; Luta G; Jayasekera J; Meza R; Stanton CA; Niaura RS; Abrams DB; McKee B; Howell J; Ramsaier M; Batlle J; Dornelas E; Parikh V; Anderson E
    Contemp Clin Trials; 2019 Jul; 82():25-35. PubMed ID: 31129371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tobacco quitline setting as a teachable moment: The Educating Quitline Users About Lung (EQUAL) cancer screening randomized trial.
    Webster M; Whealan J; Williams RM; Eyestone E; Le A; Childs J; Kao JY; Martin M; Wolfe S; Yang F; Hung PY; Lau YK; Luta G; Tammemagi M; Meza R; Taylor KL
    Transl Behav Med; 2023 Sep; 13(10):736-747. PubMed ID: 37616531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engaging Patients in Smoking Cessation Treatment within the Lung Cancer Screening Setting: Lessons Learned from an NCI SCALE Trial.
    Williams RM; Eyestone E; Smith L; Philips JG; Whealan J; Webster M; Li T; Luta G; Taylor KL; On Behalf Of The Lung Screening Tobacco Health Trial
    Curr Oncol; 2022 Mar; 29(4):2211-2224. PubMed ID: 35448154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Physician Discussions on Lung Cancer Screening: A Missed Teachable Moment to Promote Smoking Cessation.
    Kathuria H; Koppelman E; Borrelli B; Slatore CG; Clark JA; Lasser KE; Wiener RS
    Nicotine Tob Res; 2020 Mar; 22(3):431-439. PubMed ID: 30476209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.
    Rojewski AM; Tanner NT; Dai L; Ravenel JG; Gebregziabher M; Silvestri GA; Toll BA
    Chest; 2018 Jul; 154(1):110-118. PubMed ID: 29793736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Utilization of Lung Cancer Screening Through Incorporating a Video-Based Educational Tool Into Smoking Cessation Counseling.
    Raz DJ; Ismail MH; Haupt EC; Sun V; Park S; Alem AC; Gould MK
    Clin Lung Cancer; 2021 Mar; 22(2):83-91. PubMed ID: 33436279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Optimizing Lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing Lung Screening.
    Foley KL; Dressler EV; Weaver KE; Sutfin EL; Miller DP; Bellinger C; Kittel C; Stone RJ; Petty WJ; Land SR; Spangler JG; Lesser GJ; Chiles C;
    Chest; 2023 Aug; 164(2):531-543. PubMed ID: 36931460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.
    Graham AL; Burke MV; Jacobs MA; Cha S; Croghan IT; Schroeder DR; Moriarty JP; Borah BJ; Rasmussen DF; Brookover MJ; Suesse DB; Midthun DE; Hays JT
    Trials; 2017 Nov; 18(1):568. PubMed ID: 29179734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
    Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
    Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in amount smoked and readiness to quit among patients undergoing lung cancer screening.
    Deros DE; Hagerman CJ; Kramer JA; Anderson ED; Regis S; McKee AB; McKee BJ; Stanton CA; Niaura R; Abrams DB; Ramsaier M; Fallon S; Harper H; Taylor KL
    J Thorac Dis; 2021 Aug; 13(8):4947-4955. PubMed ID: 34527333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating tobacco treatment into lung cancer screening practices: Study protocol for the Screen ASSIST randomized clinical trial.
    Neil JM; Marotta C; Gonzalez I; Chang Y; Levy DE; Wint A; Harris K; Hawari S; Noonan E; Styklunas G; Crute S; Howard SE; Sheppard J; Lennes IT; Jacobson F; Flores EJ; Haas JS; Park ER; Rigotti NA
    Contemp Clin Trials; 2021 Dec; 111():106586. PubMed ID: 34606988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking Cessation in the ITALUNG Lung Cancer Screening: What Does "Teachable Moment" Mean?
    Pistelli F; Aquilini F; Falaschi F; Puliti D; Ocello C; Lopes Pegna A; Carozzi FM; Picozzi G; Zappa M; Mascalchi M; Paci E; Carrozzi L;
    Nicotine Tob Res; 2020 Aug; 22(9):1484-1491. PubMed ID: 31504798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of Smoking Cessation Resources in the Context of In-Person Shared Decision-Making for Lung Cancer Screening.
    Shen J; Crothers K; Kross EK; Petersen K; Melzer AC; Triplette M
    Chest; 2021 Aug; 160(2):765-775. PubMed ID: 33745990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.